Cargando…
Transcription factor HNF4α2 promotes osteogenesis and prevents bone abnormalities in mice with renal osteodystrophy
Renal osteodystrophy (ROD) is a disorder of bone metabolism that affects virtually all patients with chronic kidney disease (CKD) and is associated with adverse clinical outcomes including fractures, cardiovascular events, and death. In this study, we showed that hepatocyte nuclear factor 4α (HNF4α)...
Autores principales: | Martinez-Calle, Marta, Courbon, Guillaume, Hunt-Tobey, Bridget, Francis, Connor, Spindler, Jadeah, Wang, Xueyan, dos Reis, Luciene M., Martins, Carolina S.W., Salusky, Isidro B., Malluche, Hartmut, Nickolas, Thomas L., Moyses, Rosa M.A., Martin, Aline, David, Valentin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231994/ https://www.ncbi.nlm.nih.gov/pubmed/37079387 http://dx.doi.org/10.1172/JCI159928 |
Ejemplares similares
-
Bone-derived C-terminal FGF23 cleaved peptides increase iron availability in acute inflammation
por: Courbon, Guillaume, et al.
Publicado: (2023) -
Bone Canopies in Pediatric Renal Osteodystrophy
por: Pereira, Renata C., et al.
Publicado: (2016) -
Correction: Bone Canopies in Pediatric Renal Osteodystrophy
por: Pereira, Renata C., et al.
Publicado: (2016) -
Sclerostin, Osteocytes, and Wnt Signaling in Pediatric Renal Osteodystrophy
por: Laster, Marciana, et al.
Publicado: (2023) -
Renal osteodystrophy in the obesity era: Is metabolic syndrome relevant?
por: Da Silva Martins, Janaina, et al.
Publicado: (2017)